MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,001 | -12.4% | 645,490 | -19.4% | 0.00% | 0.0% |
Q2 2023 | $2,283 | -31.6% | 800,776 | -5.4% | 0.00% | -50.0% |
Q1 2023 | $3,336 | +31.3% | 846,828 | +32.0% | 0.00% | +100.0% |
Q4 2022 | $2,540 | -99.9% | 641,353 | +18.6% | 0.00% | -80.0% |
Q3 2022 | $4,968,000 | +281.6% | 540,582 | +155.3% | 0.01% | +400.0% |
Q2 2022 | $1,302,000 | -10.5% | 211,710 | -6.6% | 0.00% | 0.0% |
Q1 2022 | $1,455,000 | -45.3% | 226,710 | -44.2% | 0.00% | – |
Q4 2021 | $2,658,000 | +131.9% | 406,026 | +102.3% | 0.00% | -100.0% |
Q3 2021 | $1,146,000 | +2.2% | 200,688 | -1.6% | 0.00% | 0.0% |
Q2 2021 | $1,121,000 | +23.3% | 203,901 | +30.0% | 0.00% | – |
Q1 2021 | $909,000 | +263.6% | 156,876 | +320.4% | 0.00% | – |
Q4 2020 | $250,000 | -8.4% | 37,315 | 0.0% | 0.00% | – |
Q3 2020 | $273,000 | +93.6% | 37,315 | 0.0% | 0.00% | – |
Q2 2020 | $141,000 | – | 37,315 | +76053.1% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 49 | -94.6% | 0.00% | – |
Q4 2019 | $14,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |